Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study

✍ Scribed by Marta Pestrin, Silvia Bessi, Fabio Puglisi, Alessandro M. Minisini, Giovanna Masci, Nicola Battelli, Alberto Ravaioli, Lorenzo Gianni, Roberta Di Marsico, Carlo Tondini, Stefania Gori, Charles R. Coombes, Justin Stebbing, Laura Biganzoli, Marc Buyse, et al

• Book ID: 113062473
• Publisher: Springer US
• Year: 2012
• Tongue: English
• Weight: 246 KB
• Volume: 134
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-012-2045-1